News

Filter

Current filters:

LegalAmylin

Briefs: Pfizer $142 million fine upheld; Bristol-Myers shuts Amylin facility

05-04-2013

The US Court of Appeals in Boston has upheld a $142.1 million damage award to Kaiser Foundation Health…

AmylinBristol-Myers SquibbLegalManagementMarkets & MarketingNeurontinNorth AmericaPfizerPharmaceutical

Judge vacates Amylin injunction against Eli Lilly; latter updates Humalog label

09-06-2011

It was a good news day for US drug major Eli Lilly (NYSE: LLY) yesterday, as the firm received approval…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionHumalogLegallinagliptinNorth AmericaPharmaceuticalRegulation

Amylin wins first round in squabble with Lilly over diabetes link with Boehringer

27-05-2011

In an initial win for US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), the US District Court for…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionLegallinagliptinNorth AmericaPharmaceuticalTradjenta

Amylin sues Eli Lilly, alleging anti-competitive activity

17-05-2011

San Diego, USA-based Amylin Pharmaceuticals (Nasdaq: AMLN) has filed a law suit against drug major Eli…

AmylinBoehringer IngelheimByettaDiabetesEli LillyLegallinagliptinPharmaceuticalTradjenta

COMPANY SPOTLIGHT

Menarini

Back to top